About Real-World Evidence: New ISPOR Microsite

March 11, 2022

ISPOR has announced the launch of its new microsite, “About Real-World Evidence.” This resource, produced in partnership with the Bristol Myers Squibb-Pfizer Alliance, provides content to introduce healthcare professionals to the real-world evidence (RWE) and health economics and outcomes research (HEOR) fields. In doing so, ISPOR and partners also hope to shine a spotlight on best practices when using real-world data (RWD) and RWE.

According to ISPOR’s press release, “While RWE offers tremendous potential, concerns exist such as biases that can result due to lack of randomization, insufficient uniform data quality, and the potential for “data mining” where analyses are conducted until the desired result is found. The Real-World Evidence Transparency Initiative has been working to address these concerns by establishing a culture of transparency for the analysis and reporting of RWE.”

Read the entire press release by clicking here.

(Source: ISPOR, March 8th, 2022)

Share This Story!